These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 22437488)
1. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement. Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488 [TBL] [Abstract][Full Text] [Related]
2. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416 [TBL] [Abstract][Full Text] [Related]
3. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution. Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration. Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977 [TBL] [Abstract][Full Text] [Related]
5. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation. Sarode AL; Sandhu H; Shah N; Malick W; Zia H Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847 [TBL] [Abstract][Full Text] [Related]
6. Study the influence of formulation process parameters on solubility and dissolution enhancement of efavirenz solid solutions prepared by hot-melt extrusion: a QbD methodology. Pawar J; Suryawanshi D; Moravkar K; Aware R; Shetty V; Maniruzzaman M; Amin P Drug Deliv Transl Res; 2018 Dec; 8(6):1644-1657. PubMed ID: 29426975 [TBL] [Abstract][Full Text] [Related]
7. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization. Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284 [TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. Andrews GP; AbuDiak OA; Jones DS J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757 [TBL] [Abstract][Full Text] [Related]
9. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion. Zhang Y; Luo R; Chen Y; Ke X; Hu D; Han M AAPS PharmSciTech; 2014 Jun; 15(3):560-8. PubMed ID: 24570374 [TBL] [Abstract][Full Text] [Related]
10. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach. Pawar J; Tayade A; Gangurde A; Moravkar K; Amin P Eur J Pharm Sci; 2016 Jun; 88():37-49. PubMed ID: 27049050 [TBL] [Abstract][Full Text] [Related]
11. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying. Tian Y; Caron V; Jones DS; Healy AM; Andrews GP J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445 [TBL] [Abstract][Full Text] [Related]
12. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement. Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810 [TBL] [Abstract][Full Text] [Related]
13. Crystal growth formation in melt extrudates. Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578 [TBL] [Abstract][Full Text] [Related]
15. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier. Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809 [TBL] [Abstract][Full Text] [Related]
16. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions. Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427 [TBL] [Abstract][Full Text] [Related]
17. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects. Prasad D; Chauhan H; Atef E J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860 [TBL] [Abstract][Full Text] [Related]
18. Hot melt extrusion for amorphous solid dispersions: temperature and moisture activated drug-polymer interactions for enhanced stability. Sarode AL; Sandhu H; Shah N; Malick W; Zia H Mol Pharm; 2013 Oct; 10(10):3665-75. PubMed ID: 23961978 [TBL] [Abstract][Full Text] [Related]
19. In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw extruder using Raman spectroscopy. Saerens L; Ghanam D; Raemdonck C; Francois K; Manz J; Krüger R; Krüger S; Vervaet C; Remon JP; De Beer T Eur J Pharm Biopharm; 2014 Aug; 87(3):606-15. PubMed ID: 24657540 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion. Feng J; Xu L; Gao R; Luo Y; Tang X Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]